Top Markets
Coin of the day
GSK plc GSK plc

GSK plc

GSK
Rangering i aksjer #9382
GSK plc is a global pharmaceutical and healthcare company, deeply involved in... GSK plc is a global pharmaceutical and healthcare company, deeply involved in the research, development, production, and commercialization of a diverse range of medicinal and wellness products. Its operations span the United Kingdom, the United States, and numerous other international markets. The company structures its operations across four primary divisions: Pharmaceuticals, Pharmaceutical R&D, Vaccines, and Consumer Healthcare. Within its Pharmaceuticals segment, GSK provides treatments addressing a wide array of therapeutic areas. These include respiratory conditions, HIV, immuno-inflammatory diseases, oncology, viral infections, central nervous system disorders, cardiovascular and urogenital health, metabolic imbalances, bacterial infections, and dermatological issues. The Consumer Healthcare division offers products across categories such as wellness, oral hygiene, nutritional supplements, and skin health. These consumer offerings come in a variety of formats, including oral dosage forms (e.g., tablets, syrups, lozenges, gummies, soft chews, effervescents), topical applications (e.g., gels, creams, patches, lip balms), nasal sprays, and a comprehensive range of oral hygiene products (e.g., toothpastes, mouthwashes, denture care items), alongside other specialized formulations like infant drops and wipes. GSK actively engages in various collaborative ventures. Its collaboration agreements include partnerships with 23andMe, Lyell Immunopharma, Inc., Novartis, Sanofi SA, Surface Oncology, Progentec Diagnostics, Inc., Alector, Inc., and CureVac AG. Additionally, the company maintains strategic alliances with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. Originally established in 1715, the company operated under the name GlaxoSmithKline plc until its rebranding to GSK plc in May 2022. Its corporate headquarters are situated in Brentford, United Kingdom.
Aksjekurs
$25.28
Sist synkronisert: 2026-09-18
Markedsverdi
$1.01B
Endring (1 dag)
-2.29%
Endring (1 år)
-37.84%
Land
GB
Handel GSK plc (GSK)

Kategori

Inntekter for GSK plc (GSK)
Inntekter i Jun 2026 TTM: $45.18B
Ifølge de nyeste økonomiske rapportene til GSK plc er selskapets nåværende inntekter (TTM) $45.18B. I 2024 hadde selskapet inntekter på $39.37B en økning sammenlignet med inntektene i 2023, som var $38.61B. Inntektene er det totale beløpet et selskap genererer fra salg av varer eller tjenester. I motsetning til fortjeneste trekkes ingen kostnader fra.
Inntektshistorikk for GSK plc fra 2000 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
2026 (TTM) $45.18B 5.15%
2025 $42.97B 9.13%
2024 $39.37B 1.98%
2023 $38.61B 8.83%
2022 $35.48B 6.25%
2021 $33.39B 0.28%
2020 $33.30B -25.61%
2019 $44.76B 14.02%
2018 $39.26B -3.77%
2017 $40.79B 18.52%
2016 $34.42B -2.36%
2015 $35.25B -1.64%
2014 $35.84B -18.35%
2013 $43.90B 2.38%
2012 $42.87B 0.88%
2011 $42.50B -3.83%
2010 $44.19B -3.75%
2009 $45.91B 29.14%
2008 $35.55B -21.53%
2007 $45.31B -0.48%
2006 $45.53B 22.17%
2005 $37.27B -2.94%
2004 $38.40B 0.32%
2003 $38.27B 12.00%
2002 $34.17B 14.47%
2001 $29.85B 10.60%
2000 $26.99B 0.00%
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
$79.67B 76.33%
US
$97.93B 116.76%
US
$64.39B 42.51%
US
$77.52B 71.58%
CH
$66.40B 46.97%
US